MARKET

INSM

INSM

Insmed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.18
-0.48
-2.32%
Closed 16:10 11/20 EST
OPEN
20.50
PREV CLOSE
20.66
HIGH
20.89
LOW
19.99
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
33.13
52 WEEK LOW
11.31
MARKET CAP
1.80B
P/E (TTM)
-5.5484
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of INSM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

INSM News

  • Edited Transcript of INSM earnings conference call or presentation 30-Oct-19 12:30pm GMT
  • Thomson Reuters StreetEvents.3d ago
  • Insmed Appoints Dr. Clarissa Desjardins to its Board of Directors and Names Roger Adsett Chief Operating Officer
  • PR Newswire.6d ago
  • Insmed to Present at Two November Conferences
  • PR Newswire.11/05 13:00
  • Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • PR Newswire.11/04 21:05

More

Industry

Biotechnology & Medical Research
+0.65%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About INSM

Insmed Incorporated is a global biopharmaceutical company. The Company’s product ARIKAYCE (amikacin liposome inhalation suspension) is developed for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The Company's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that offers a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.
More

Webull offers Insmed Incorporated (INSM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.